Longevity PapersAbout
← All papers
RESEARCH PAPER / 2026-08-09

Lymphatic CD49a is a driver of meningeal immune aging and cognitive decline.

Frederick, N. M., Tinkey, R., Tavares, G. A., Dahnke, C. N., Busch, H., Arun, N., Chung, L., Buxbaum, A. D., Louveau, A.

Cleveland Clinic ResearchCleveland Clinic Research · biorxiv

Abstract

Aging is associated with progressive accumulation and dysregulation of dural immune cells, coinciding with impaired CSF drainage and lymphatic function. Prior work has shown that improving lymphatic function in aged mice is sufficient to ameliorate age-associated cognitive decline, and that local immune cells can directly regulate lymphatic draining function. Yet, the endothelial-intrinsic mechanisms driving lymphatic dysfunction remain unclear. Here we found that the integrin CD49a is upregulated in aged lymphatic endothelial cells and regulates CCL21 release. Accordingly, genetic deletion of CD49a in lymphatic endothelial cells broadly reverses age-associated immune dysfunction across dural myeloid, lymphoid and dendritic cell compartments, limits glial aging, and mitigates cognitive and social behavioral deficits, thereby revealing a targetable endothelial-intrinsic mechanism of lymphatic aging.

The following analysis is generated by AI and may contain errors. It is separate from the authors’ abstract and is not peer review.

Research summary

Genetic deletion of the integrin CD49a in lymphatic endothelial cells reverses age-associated immune dysfunction and cognitive decline in mice by restoring lymphatic drainage function. This paper is relevant because it identifies a specific endothelial-intrinsic mechanism driving lymphatic aging, a key process in waste clearance and immune regulation, and demonstrates that targeting this root cause can mitigate systemic aging phenotypes rather than just treating downstream symptoms.

Author of this paper? Send a correction.